Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endoplasmic reticulum junction formation protein lunapark (LNPK) is a conserved ER-shaping membrane protein characterized by two transmembrane domains and a zinc finger motif that is essential for its function. LNPK localizes specifically to three-way junctions of the ER network, where it stabilizes nascent junctions and modulates ER morphology by promoting network stability and limiting excessive junction mobility. Loss or depletion of LNPK disrupts ER morphology, shifting the network from a reticulated structure toward expanded sheets, and is associated with neurodevelopmental disorders such as epilepsy and hypoplasia of the corpus callosum. Although its direct role as a therapeutic target is not established, LNPK is essential for cellular homeostasis and proper ER function[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endoplasmic reticulum junction formation protein lunapark (LNPK).